Asset Details
Do you wish to reserve the book?
Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome
Do you wish to request the book?
Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome
2024
Overview
Mitochondrial diseases are mainly caused by dysfunction of mitochondrial respiratory chain complexes and have a variety of genetic variants or phenotypes. There are only a few approved treatments, and fundamental therapies are yet to be developed. Leigh syndrome (LS) is the most severe type of progressive encephalopathy. We previously reported that apomorphine, an anti- “off” agent for Parkinson’s disease, has cell-protective activity in patient-derived skin fibroblasts in addition to strong dopamine agonist effect. We obtained 26 apomorphine analogs, synthesized 20 apomorphine derivatives, and determined their anti-cell death effect, dopamine agonist activity, and effects on the mitochondrial function. We found three novel apomorphine derivatives with an active hydroxy group at position 11 of the aporphine framework, with a high anti-cell death effect without emetic dopamine agonist activity. These synthetic aporphine alkaloids are potent therapeutics for mitochondrial diseases without emetic side effects and have the potential to overcome the low bioavailability of apomorphine. Moreover, they have high anti-ferroptotic activity and therefore have potential as a therapeutic agent for diseases related to ferroptosis.
Publisher
Springer Science and Business Media LLC,Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/45
/ 692/308
/ 692/699
/ Agonists
/ Apomorphine - analogs & derivatives
/ Apomorphine - therapeutic use
/ Aporphines - chemical synthesis
/ Aporphines - therapeutic use
/ Dopamine
/ Dopamine Agonists - chemistry
/ Dopamine Agonists - pharmacology
/ Dopamine Agonists - therapeutic use
/ Humanities and Social Sciences
/ Humans
/ Leigh Disease - drug therapy
/ Medicine
/ Q
/ R
/ Science
